The Patient Engagement Collaborative (PEC) brings together 16 diverse representatives from the patient community to meet with the FDA several times a year and discuss how to achieve more meaningful patient engagement in medical product development and other regulatory discussions. The PEC, launched in December 2017, is a joint effort of CTTI and the FDA. Click here to review the PEC Framework.
Now through August 23, 2021, we are requesting applications from patient advocates interested in becoming members of the PEC. The PEC will accept up to eight new members for two-year terms starting in September 2021.
Current members of the PEC include: